beta
ONS
Oncobiologics Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
Actual EPS |
---|
Consensus EPS |
Estimated EPS |
Number of Estimates |
EPS Surprise |
Stats
Summary
Oncobiologics Inc is a clinical-stage biopharmaceutical company. It is engaged in identifying, developing, manufacturing and commercializing complex biosimilar therapeutics in the disease areas of immunology and oncology.
Market Cap: 30.4 Million
Primary Exchange: NASDAQ Global Market
Website: http://www.oncobiologics.com
Shares Outstanding: 25.5 Million
Float: 17.5 Million
Dividend: 0.0 (0.0%)
Beta: -0.674909
Sector: Healthcare
Industry: Biotechnology
Ethical Flags
Longest drawdown: 679 trading days
From: 2016-09-06 To: 2018-12-03
Lowest Point:
Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
---|
Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
---|